EX-FILING FEES 6 d332162dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107.1

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Corvus Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price
  Fee
Rate
  Amount of
Registration
Fee
 

Carry
Forward

Form
Type

 

Carry

Forward

File

Number

  Carry
Forward
Initial
Effective
date
  Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         

Fees to Be

Paid

                         
                         
    Equity   Common Stock, par value $0.0001 per share     (1)(2)    (1)    (3)               
                         
    Equity   Preferred Stock, par value $0.0001 per share     (1)(2)    (1)    (3)               
                         
    Debt   Debt Securities     (1)    (1)    (3)               
                         
    Other   Warrants     (1)    (1)    (3)               
                         
    Other   Units     (1)    (1)    (3)               
                         
    Unallocated (Universal) Shelf     Rule 457(o)   (1)    (1)     $100,000,000(3)     $0.0001102     $11,020.00(4)           
 
Carry Forward Securities
                         

Carry Forward

Securities

                       
                   
    Total Offering Amounts     

$100,000,000

    $11,020.00          
                   
    Total Fees Previously Paid         

         
                   
    Total Fee Offsets         

         
                   
    Net Fee Due               

$11,020.00

               

 

(1)

An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional shares of Common Stock is being registered as may be issued from time to time upon conversion of any Debt Securities that are convertible into Common Stock or pursuant to any anti-dilution adjustments with respect to any such convertible Debt Securities.

(2)

Includes rights to acquire common stock or preferred stock of the Company under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

(3)

Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities, depositary shares or preferred stock or upon exercise of common stock warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $100,000,000.

(4)

Calculated pursuant to Rule 457(o) under the Securities Act.